You are here: Industry Insights > Novavax

News List

Novavax seeks emergency use listing from WHO for Covid-19 vaccine Pharmaceutical-Business-Review
November 09, 2021
Novavax has completed the rolling submission to the World Health Organization (WHO) for emergency use listing (EUL) of its Covid-19 vaccine candidate, NVX-CoV2373.
Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization prnasia
November 05, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion...
Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Rolling Review Submission to European Medicines Agency AmericanPharmaceuticalReview
November 02, 2021
Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion of its rolling submission...
Novavax COVID-19 Vax Receives First Authorization ContractPharma
November 02, 2021
Novavax, Inc. and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by volume, announced that the National Agency of Drug and Food Control of the Republic of Indonesia...
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia prnasia
November 02, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII)...
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia prnasia
November 01, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion...
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom prnasia
October 28, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion...
Novavax defends COVID-19 vaccine manufacturing processes after claims of quality issues CPhIonline
October 21, 2021
US biotech Novavax has defended its manufacturing processes after a recent report which claimed the company was struggling to meet US Food and Drug Administration quality standards in the production of its COVID-19 vaccine.
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases prnasia
September 28, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced publication...
Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine prnasia
September 28, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, with its partner...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page